Differential expression of p-erm, a marker of cell polarity, in benign and neoplastic oviductal epithelium

International Journal of Gynecological Pathology

Volumn 32, Issue 4, 2013, Pages 345-352

  Ning, Gang ^a   Bijron, Jonathan G ^b   Yuan, Ju ^a,b   Hirsch, Michelle S ^b   McKeon, Frank D ^a,b,c   Nucci, Marisa R ^b   Crum, Christopher P ^b   Xian, Wa ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

Fallopian tube; Intraepithelial carcinoma; polarity; Serous cancer

Indexed keywords

EZRIN RADAXIN MOESIN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CYTOSKELETON PROTEIN; EZRIN; MEMBRANE PROTEIN; MOESIN; RADIXIN;

ARTICLE; CELL POLARITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA; TUBAL INTRAEPITHELIAL LESION IN TRANSITION; UTERINE TUBE CARCINOMA; CARCINOMA IN SITU; CELL PROLIFERATION; CYSTADENOCARCINOMA; EPITHELIUM; METABOLISM; MUCOSA; OVARY TUMOR; PATHOLOGY; PELVIS TUMOR; PHOSPHORYLATION; UTERINE TUBE; UTERINE TUBE TUMOR;

CARCINOMA IN SITU; CELL POLARITY; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; CYTOSKELETAL PROTEINS; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MUCOUS MEMBRANE; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PHOSPHORYLATION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880199668     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31826feee2     Document Type: Article

References (11)

1. Drapkin R, Crum CP, Hecht JL. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia. Hum Pathol 2004;35:1014-21. (Pubitemid 39037185)
2. Cass I, Holschneider C, Datta N, et al. BRCA-mutationassociated fallopian tube carcinoma: A distinct clinical phenotype? Obstet Gynecol 2005;106:1327-34. (Pubitemid 41668953)
3. Folkins AK, Jarboe EA, Roh MH, et al. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 2009;113:391-6.
4. Lee Y, Miron A, Drapkin R, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007;211:26-35. Erratum in: J Pathol. 2007;213:116. (Pubitemid 46092026)
5. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: A descriptive classification. Int J Gynecol Pathol 2008;27:1-9. (Pubitemid 351627965)
6. Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34:1407-16. Erratum in: Am J Surg Pathol. 2010;34:1891.
7. Carlson JW, Jarboe EA, Kindelberger D, et al. Serous tubal intraepithelial carcinoma: Diagnostic reproducibility and its implications. Int J Gynecol Pathol 2010;29:310-4.
8. Visvanathan K, Vang R, Shaw P, et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: A reproducibility study. Am J Surg Pathol 2011;35:1766-75.
9. Tsukita S, Yonemura S. Cortical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem 1999;274:34507-10. (Pubitemid 129509480)
10. Tran Quang C, Gautreau A, Arpin M, et al. Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J 2000;19:4565-76.
11. Kobayashi H, Sagara J, Masumoto J, et al. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma. J Oral Pathol Med 2003;32:344-9. (Pubitemid 36781533)